PharmaceuticalsMid-Size Pharmaceutical Company

Growing Patient Support Program at a Mid-Size Pharmaceutical

Journey MappingPersona BuildoutsCreative & Content AuditsCross-Functional Communication Strategies

The Challenge

Program enrollments were low despite therapy availability and usage. Limited awareness, inconsistent engagement, and insufficient field tools left patients, care partners, and providers without full access to support.

The Grovery Alignment Impact

Through comprehensive field research, cross-functional alignment, content audits, and gap analyses, we redefined the program's engagement strategy. The framework provided targeted messaging, optimized tools, and a clear roadmap to increase enrollments, deepen engagement, and prepare for future therapy launches.

Genmab case study image 1

Digital enrollment guides streamline patient onboarding, offering clear, accessible pathways and support resources for HCPs.

Genmab case study image 2

Emotionally resonant patient-facing materials strengthen early awareness and drive program enrollment for patients and care partners.

Genmab case study image 3

Event signage increases program visibility and awareness at conferences and trade shows.

Genmab case study image 4

Patient discussion guides facilitate meaningful HCP-patient conversations, improving engagement at critical decision-making moments.

Align

Mapped patient, provider, and care partner journeys to identify access barriers and unmet support needs, analyzed reimbursement and competitive landscapes, and coordinated across agencies to unify strategy and execution. Pinpointed missing tools and touchpoints through gap analyses.

Advise

Built a roadmap and launch readiness plan to unify streams within one PSP platform, auditing content and messaging, refreshing the engagement strategy playbook, and recommending tools and resources to elevate program visibility and impact.

Activate

Developed enrollment-focused team tools and patient/care partner resources with emotionally resonant content shaped by insights from key audiences in the Align stage. Built engagement tactics with measurable tracking. Strengthened early awareness, enrollment, and adoption of new therapies within the PSP via the refined strategy.